Major depressive disorder (mdd) Trials in Houston, United States
Conditions / Major depressive disorder (mdd) / Houston, United States
Major depressive disorder (mdd) is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00067444 | Depression Study In Elderly Patients | COMPLETED | PHASE3 |
| NCT01187407 | A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment | COMPLETED | PHASE3 |
| NCT06836063 | Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00411242 | Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01912196 | Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE2 |
| NCT00057239 | An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder | COMPLETED | PHASE2 |
| NCT06793397 | A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | RECRUITING | — |
| NCT02109939 | Genomics Used to Improve DEpression Decisions | COMPLETED | NA |
| NCT00064467 | Lethargic Depression Study | COMPLETED | PHASE3 |
| NCT07284667 | ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response | RECRUITING | — |